AstroNova (NASDAQ:ALOT – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Wednesday.
AstroNova Stock Performance
NASDAQ:ALOT traded up $0.17 during midday trading on Wednesday, reaching $14.96. 15,101 shares of the company traded hands, compared to its average volume of 12,054. The firm has a market capitalization of $112.41 million, a price-to-earnings ratio of 22.67 and a beta of 0.55. The company has a fifty day moving average price of $14.63 and a 200 day moving average price of $16.23. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.07 and a quick ratio of 1.10. AstroNova has a twelve month low of $11.79 and a twelve month high of $18.83.
Institutional Trading of AstroNova
An institutional investor recently raised its position in AstroNova stock. Vanguard Group Inc. raised its holdings in shares of AstroNova, Inc. (NASDAQ:ALOT – Free Report) by 0.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 349,546 shares of the business services provider’s stock after buying an additional 2,700 shares during the period. Vanguard Group Inc. owned about 4.67% of AstroNova worth $6,229,000 as of its most recent SEC filing. 43.02% of the stock is currently owned by institutional investors.
AstroNova Company Profile
AstroNova, Inc designs, develops, manufactures, and distributes specialty printers, and data acquisition and analysis systems in the United States, Europe, Asia, Canada, Central and South America, and internationally. The company operates in two segments, Product Identification (PI) and Test & Measurement (T&M).
Featured Stories
- Five stocks we like better than AstroNova
- What is a Secondary Public Offering? What Investors Need to Know
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- With Risk Tolerance, One Size Does Not Fit All
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- 3 Fintech Stocks With Good 2021 Prospects
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for AstroNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstroNova and related companies with MarketBeat.com's FREE daily email newsletter.